Application of the Lancet Commission Criteria for the Diagnosis of Obesity to a Clinical Trials Population: The LEAP Trial
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Faith Anne N. Heeren, Kathleen R. Ruddiman, Courtney Simmons, Brian N. White, Byron C. Jaeger, Nicholas M. Pajewski, Stephanie A. Hooker, Deborah B. Horn, Katy Martin‐Fernandez, Kimberly A. Gudzune, Caroline Blackwell Young, Jamy Ard, Kristina Henderson Lewis |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2025
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Beyond BMI : Reassessing the Prevalence of Obesity in Patients With MASLD Under the Lancet Commission Diagnostic Criteria
por: Ru‐Tao Lin, et al.
Publicado: (2026)
por: Ru‐Tao Lin, et al.
Publicado: (2026)
Beyond BMI : The Impact of the New Lancet Commission Diagnostic Criteria on Prevalence of Obesity in the United States
por: Jennifer H. Hwang, et al.
Publicado: (2026)
por: Jennifer H. Hwang, et al.
Publicado: (2026)
Impact of the 2025 Lancet Diagnostic Criteria on Obesity Treatment in the United States
por: Maryna Chumakova, et al.
Publicado: (2025)
por: Maryna Chumakova, et al.
Publicado: (2025)
The latest evidence and clinical guidelines for use of meal replacements in very‐low‐calorie diets or low‐calorie diets for the treatment of obesity
por: Shenelle A. Edwards‐Hampton, et al.
Publicado: (2024)
por: Shenelle A. Edwards‐Hampton, et al.
Publicado: (2024)
Will the New Lancet Commission Classification of Obesity Only Mystify and Complicate Things in Paediatric Clinics?
por: Annika Janson
Publicado: (2025)
por: Annika Janson
Publicado: (2025)
Beyond BMI : Practical Guide for Clinicians to Integrate the Lancet Commission's Obesity Framework and King's Obesity Staging System
por: Tak Ying Louise Ko, et al.
Publicado: (2025)
por: Tak Ying Louise Ko, et al.
Publicado: (2025)
Virtual Weight Management and Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Randomized Controlled Trial
por: Peter T. Katzmarzyk, et al.
Publicado: (2026)
por: Peter T. Katzmarzyk, et al.
Publicado: (2026)
An Update on the American Board of Obesity Medicine ( ABOM ): 2017–2024
por: Brianna Johnson‐Rabbett, et al.
Publicado: (2025)
por: Brianna Johnson‐Rabbett, et al.
Publicado: (2025)
The association of frailty with cognition outcomes in SPRINT‐MIND
por: Kathryn E. Callahan, et al.
Publicado: (2024)
por: Kathryn E. Callahan, et al.
Publicado: (2024)
Interventions for people living with dementia: updates from 2024 Lancet Commission
por: Andrew Sommerlad, et al.
Publicado: (2024)
por: Andrew Sommerlad, et al.
Publicado: (2024)
Perceptions of anti‐obesity medications among people with obesity and healthcare providers in the US: Findings from the OBSERVE Study
por: Lee M. Kaplan, et al.
Publicado: (2025)
por: Lee M. Kaplan, et al.
Publicado: (2025)
Precision medicine and patient‐centered outcomes: Learning from APOE for prevention clinical trials in older adults
por: Nicholas M. Pajewski
Publicado: (2024)
por: Nicholas M. Pajewski
Publicado: (2024)
Exploring the Role of Internalized Weight Bias as a Metric of Cumulative Social Disadvantage Among People With Obesity or Overweight: Insights From the OBSERVE Study
por: Jamy Ard, et al.
Publicado: (2025)
por: Jamy Ard, et al.
Publicado: (2025)
TrialCompass: Visual Analytics for Enhancing the Eligibility Criteria Design of Clinical Trials
por: Sheng, Rui, et al.
Publicado: (2025)
por: Sheng, Rui, et al.
Publicado: (2025)
Identification of cognitive impairment using the Lancet Commission's risk factors and Medicare administrative data
por: Hankyung Jun, et al.
Publicado: (2026)
por: Hankyung Jun, et al.
Publicado: (2026)
Adherence to the EAT ‐Lancet Diet, Genetic Susceptibility and Risk of Obesity and Obesity‐Related Morbidities: A Prospective Cohort Study
por: Huan‐Cong Zheng, et al.
Publicado: (2026)
por: Huan‐Cong Zheng, et al.
Publicado: (2026)
Evolution of Eligibility Criteria in Inflammatory Bowel Disease Clinical Trials: A Clinical Trial Databank Analysis
por: An Outtier, et al.
Publicado: (2024)
por: An Outtier, et al.
Publicado: (2024)
Reassessing Dementia Risk: Expanding the 2024 Lancet Commission Report for a More Accurate Global Understanding
por: Cyprian M Mostert
Publicado: (2025)
por: Cyprian M Mostert
Publicado: (2025)
On the Calibration of Bayesian Success Criteria and Operating Characteristics for Clinical Trials
por: Yang, Peng, et al.
Publicado: (2026)
por: Yang, Peng, et al.
Publicado: (2026)
$\texttt{AMEND++}$: Benchmarking Eligibility Criteria Amendments in Clinical Trials
por: Das, Trisha, et al.
Publicado: (2026)
por: Das, Trisha, et al.
Publicado: (2026)
The Lancet Microbe
Publicado: (2020)
Publicado: (2020)
THE BIG LEAP
Publicado: (1999)
Publicado: (1999)
Contemporary Indonesian Film; Spirits of Reform and ghosts from the past
por: van Heeren, Katinka
Publicado: (2012)
por: van Heeren, Katinka
Publicado: (2012)
Waist circumference remains the better predictor of insulin resistance compared to 2025 Lancet Commission definition on clinical obesity
por: Han S. J. Chew, et al.
Publicado: (2025)
por: Han S. J. Chew, et al.
Publicado: (2025)
The Library and the Writing Centre Build a Workshop: Exploring the Impact of an Asynchronous Online Academic Integrity Course
por: Ard, Stephanie Evers, et al.
Publicado: (2019)
por: Ard, Stephanie Evers, et al.
Publicado: (2019)
Associations Between Alzheimer’s Disease and Obesity: Clinical Trials of NA‐831 for AD and NA‐931 for Obesity
por: Lloyd Tran, et al.
Publicado: (2024)
por: Lloyd Tran, et al.
Publicado: (2024)
The Lancet Public Health
Publicado: (2017)
Publicado: (2017)
The Lancet. Healthy Longevity
Publicado: (2021)
Publicado: (2021)
The Lancet Planetary Health
Publicado: (2018)
Publicado: (2018)
The Lancet Global Health
Publicado: (2013)
Publicado: (2013)
The Lancet: Digital Health
Publicado: (2019)
Publicado: (2019)
The Lancet Primary Care
Publicado: (2026)
Publicado: (2026)
Twelve‐month analysis of real‐world evidence from a telehealth obesity‐treatment provider using antiobesity medications
por: Jamy D. Ard, et al.
Publicado: (2024)
por: Jamy D. Ard, et al.
Publicado: (2024)
Weight Loss, Obesity Medication, and Risk of Obesity‐Associated Cancer: A Meta‐Analysis of Randomized Controlled Trials
por: Chengwen Li, et al.
Publicado: (2025)
por: Chengwen Li, et al.
Publicado: (2025)
Adjusting for Selection Bias Due to Missing Eligibility Criteria in Emulated Target Trials
por: Benz, Luke, et al.
Publicado: (2024)
por: Benz, Luke, et al.
Publicado: (2024)
Target Trial Emulation for Clarity of Causal Questions
por: Jeffrey N. Bone
Publicado: (2026)
por: Jeffrey N. Bone
Publicado: (2026)
“We Have Never Seen These Things in Our Entire Lives”: Perceived Impacts of and Responses to Climate Change Among Sidama Agropastoralists Residing Near Hawassa, Ethiopia
por: Eden Blackwell, et al.
Publicado: (2025)
por: Eden Blackwell, et al.
Publicado: (2025)
The Lancet Regional Health. Europe
Publicado: (2021)
Publicado: (2021)
The Lancet Regional Health. Americas
Publicado: (2021)
Publicado: (2021)
The Lancet Countdown on health and plastics.
por: Landrigan, Philip J, et al.
Publicado: (2025)
por: Landrigan, Philip J, et al.
Publicado: (2025)
Ejemplares similares
-
Beyond BMI : Reassessing the Prevalence of Obesity in Patients With MASLD Under the Lancet Commission Diagnostic Criteria
por: Ru‐Tao Lin, et al.
Publicado: (2026) -
Beyond BMI : The Impact of the New Lancet Commission Diagnostic Criteria on Prevalence of Obesity in the United States
por: Jennifer H. Hwang, et al.
Publicado: (2026) -
Impact of the 2025 Lancet Diagnostic Criteria on Obesity Treatment in the United States
por: Maryna Chumakova, et al.
Publicado: (2025) -
The latest evidence and clinical guidelines for use of meal replacements in very‐low‐calorie diets or low‐calorie diets for the treatment of obesity
por: Shenelle A. Edwards‐Hampton, et al.
Publicado: (2024) -
Will the New Lancet Commission Classification of Obesity Only Mystify and Complicate Things in Paediatric Clinics?
por: Annika Janson
Publicado: (2025)